Unlocking the Rigid Spine
New clinical data confirms the efficacy of robotic spinal mobilization for Parkinson's motor symptoms.
Registered Medical Device
BackHug is registered with the MHRA as a Class I Medical Device for the relief of muscle tension, spasm, and stiffness. We operate at the intersection of engineering precision and clinical safety.
Pilot Study Results (N=16)
In our 2025 pilot study, we tested the hypothesis that releasing Axial Rigidity (the 'Concrete Body') directly improves systemic mobility. The results were consistent and compelling.
MOBILITY
Improvement in Gait Speed
Participants moved faster and with greater fluidity.
STRENGTH
Improvement in Sit-to-Stand
Functional leg power increased significantly.
PAIN
Reduction in Chronic Pain
Severe back pain scores dropped to near-zero.
Quantifying the Release
In a separate validation study (N=13), we used the Myoton Pro—the gold standard device for measuring soft tissue properties—to verify the physical impact of BackHug on spinal muscles.
The Objective Proof
We compared the mechanical stiffness of back muscles before and after a single robotic session.
The results confirmed that BackHug does not just 'soothe' the back; it structurally alters muscle tone.
WHAT USERS FELT
44%
Reduction in Discomfort
WHAT THE SENSOR
MEASURED
376%
Reduction in Stiffness
(Relative to Control)
Conclusion
This data validates our core mechanism: Consistent robotic pressure creates measurable physical change in deep spinal tissues.
The Path to Clinical Validation
From foundational science to medical standard.
2022
Mechanism of Action
Study: The Spinemap Validation (N=13)
Key Finding: Myoton Pro sensors confirmed a 376% objective reduction in spinal stiffness.
Result: Proved that robotic fingers physically loosen deep tissue.
2025
Clinical Outcomes
Study: Edinburgh Parkinson's Pilot (N=16)
Key Finding: Validated the link between releasing rigidity and improving mobility. 25% faster gait and 65% less pain.
Result: Established BackHug as a potential adjunct therapy for PD.
2026
Medical Certification
Milestone: MHRA Class I Registration
Status: BackHug is now a registered medical device in the UK for the relief of muscle tension and stiffness.
Result: Transition from "Wellness Device" to "Medical Device."
TODAY
Large-Scale Validation
Program: US & UK Home Trials
Goal: Collecting real-world efficacy data from 100+ daily users with Parkinson's.
Result: Expanding the evidence base from the clinic to the home.
NEXT
The Global Standard
Goal: FDA Class II Clearance
Plan: Pivotal multi-site clinical trials to secure indication for the treatment of Parkinson's symptoms.
Result: Insurance reimbursement and accessibility for all patients.
Join the next phase of our research.